Autopsy report · NCT04218565

Golimumab for the Treatment of Refractory Behcet's Uveitis

“only one patient enrolled”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 2 years 10 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Wenjie Zheng

Sponsor type

University, hospital or other

Conditions

Behcet Syndrome; Uveitis

Interventions

Golimumab (GOL)

Participants

1

Sites

1

Countries

China

Trials that died the same way

• Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
  “no enough enrolled patients” (76% match in meaning)
• The Effect of Pain Medication in Children With Acute Abdominal Pain and Its Implication Over the Surgeon's Decision
  “Unable to enroll more patients” (72% match in meaning)
• Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome
  “Only 2 participants were enrolled” (71% match in meaning)
• Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit
  “Only one patient was enrolled. Due to low accrual study was terminated” (71% match in meaning)
• Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility
  “No further patient enrollment” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.